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A cDNA clone with the coding sequence for the 230-kD 
bullous pemphioid (BP) antigen was isolated from a mouse 
cDNA expression library by using an anti-basement mem-
brane zone human monoclonal antibody (MoAb-5E). The 
Agt11 cDNA expression library was constructed from 
poly(A)+ RNA from the mouse epidermal cell line, Pam cells, 
by random priming. 1.5 X 105 recombinant clones were 
screened by immunostaining with MoAb-5E and one posi-
tive clone (BPM1) was obtained. All of the ten BP sera but 
none of the nve normal or seven pemphigus sera tested 
reacted with the fusion protein produced by BPM1. The size 
of the eDNA was 3.2 kb. Northern blot analysis indicated 
that BPM1 eDNA hybridized to a mRNA of about 9 kb, 
"""\ 
which is large enough to encode for a 230-kD protein. DN1\, 
sequencing demonstrated a 2,991-bp open reading frame en~ 
coding a peptide of 115 kD. Sequence comparison betwee~ 
mouse and human cDNA clones revealed that the 230-lcD 
BP antigen was well conserved during evolution except fo~ 
the carboxyl terminus. Highly conserved and hydrophiliQ 
regions in the molecule were considered to be good candi, 
dates for antigenic determinants. This cDNA clone will b~ 
useful not only for diagnosis ofBP, e.g., enzyme-linked im, 
munosorbent assay using recombinant proteins or synthetiQ 
peptides as antigens, but also for pathophysiologic study ill, 
which mouse models of BP might be used. ] Invest Dermatol 
95:252-259, 1990 
------------------------------------------------------------------------------------------------------~~ 
Bullous pemphigoid (BP) is an autoimmune disease clinically characterized by tense blister formation. . Blisters develop because of cleft formation between epidermis and dermis at the basement membrane zone (BMZ). Anti-BMZ autoantibodies in the patients' sera 
are found by immunofluorescence test (1,2] . These anti-BMZ au-
toantibodies are thought to play important roles in the pathogenesis 
[3-6] . 
There is contention about the uniqueness of the BP antigen. 
Some studies have sug~ested that BP antibodies recognize a single 
unique antigen (7 -12J, whereas other studies have implied that 
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there may be heterogeneity in BP antigens [13-16]. However, :\, 
220 - 240-kD protein is generally considered to be the major Bp 
antigen as determined by immunoprecipitation or immunoblottin 
with BP patients' sera [12,17] . 
Recently we established three lymphoblastoid cell lines from a 
BP patient's peripheral blood, by means of Epstein-Barr (EB) virus 
transformation, and these lines constantly produce human monoclo_ 
nal anti-DMZ IgG antibodies [17]. One of these antibodies, desig-
nated MoAb-5E, reacted by immunoblotting exclusively with the 
230-kD protein from normal human epidermal extracts, as well as 
WIth extracts of cultured mouse epidermal cells. 
In order to further characterize this 230-kD BP antigen, we con-
structed a cDNA library, using Agtll as an expression vector, from a 
mouse epidermal cell line, Pam cells, which produces the 230-lcD 
BP antigen. This cDNA library was screened with the anti-BMZ 
human monoclonal antibody (MoAb). W e isolated one positive 
clone and confirmed that the cDNA had coding regions for the 
230-kD BP antigen. The comparison of the deduced amino acid 
sequences between mouse and human revealed the 230-kD BP anti-
gen was highly conserved during evolution and provided potential 
candidates for autoepitopes. 
MATERIALS AND METHODS 
Cell Culture Mouse epidermal Pam cells [18] were cultured ~ 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 
10% fetal calf serum (FCS), 100,ug/ml kanamycin (Meiji Seika Co. 
Tokyo, Japan) and 1 ,ug/ml of fungizone (Squibb Co., Tokyo, Ja, 
pan). Cultures were maintained at 37°C in a 95% air/5% CO~ 
humidified atmosphere. 
Human MoAb and Sera Anti-BMZ human MoAb, MoAb-SE, 
was produced by the EB-virus transformation method from a pa-
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tient w ith BP [17J . MoAb-5E was harvested from the culture me-
dium, concentrated by salt precipitation with ammonium sulfate, 
and used to screen the cDNA expression library without any pre-
treatments. 
To study the specificity of the putative BP fusion protein, we used 
sera from ten patients with bullous pemphigoid that reacted with 
the 230-kD protein by immunoblotting. We also used sera from 
fou r patients with pemphigus vulgaris, three patients with pemphi-
gus erythematosus, and five normal individuals as negative controls. 
These sera were preabsorbed for 2 h at room temperature with 
extracts of Escherichia coli YI090 cells to remove any anti-E. coli 
IgG. 
ltnmunoblot Analysis Immunoblotting was performed as 
previously described [1 7J. In brief, cultured Pam cells were placed 
on ice, scraped with a rubber policeman into SDS sample buffer [1 % 
sodium dodecyl sulfate (SDS), 10 mM Tris-HCl pH 6.8, 2 mM 
ethylenediaminetetraacetic acid (EDT A) , 2 mM phenylmethylsul-
fony l fluoride, 5% fJ-mercaptoethanol, 5 mg/ml leupeptin, anti-
pain, chymostatin, pepstatin A (Sigma, St. Louis, MO)] and homog-
enized in a glass homogenizer. The sample was boiled for 5 min and 
centrifuged. The supernatant was frozen at -70 ° C until used for 
electrophoresis. 
Proteins were separated by SDS-polyacrylamide gel electrophore-
sis (PAGE) [19], and electrophoretically transferred to a nitrocellu-
lose sheet [20J (Schleicher and Schnell, Dassel, FRG). For immuno-
peroxidase detection of BP antigens, blots were incubated with 
MoAb-5E, or with sera from BP patients or normal individuals as a 
primary antibody, and then with peroxidase-conjugated anti-llll-
man IgG rabbit antiserum (DAKO, Copenhagen, Denmark) as a 
secondary antibody. 
Construction of Agt11 Expression Library In order to find a 
cDNA clone with a coding sequence for BP antigen, we constructed 
a cDNA expression library using Agtll [21 J by random priming. 
Pam cells in 15-cm tissue-culture plates were harvested, resus-
pended to LiCl buffer (3 M LiCl, 6 M urea, 50 mM Tris-HCl, pH 
7.5, 5 mM EDT A, 0.1 M fJ-mercaptoethanol, and 0.1 % sarcosyl), 
sonicated to shear chromosomal DNA, and kept on ice overnight. 
Total RNA was pelleted by centrifugation at 13,000 X g for 45 min, 
and solubilized in TESP buffer (10 mM Tris-HCl , pH 7.5, 1 mM 
EDTA, 0.5% SDS, and 100 ,ug/ml proteinase K). Then it was ex-
tracted with CHCI3: 1-butanol (4: 1), ethanol precipitated, and dis-
solved in TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA). 
Poly(A)+ RNA was isolated from total RNA by oligo(dT)cellulose 
(Collaborative Research Inc., Bedford, MA) column chromatog-
raphy. 
cDNA was synthesized by using a cDNA synthesis kit 
(Boehringer Mannheim, Penzberg, FRG) according to the method 
recommended by the manufacturer, exce\?t for the use of random 
hexamers [p(N)6' Boehringer MannheimJ as primers. The cDNA 
were fractionated by Sepharose CL-4B (Pharmacia, Uppsala, Swe-
den) column chromatography to remove the small cDNA of less 
than 600 bp in size. Internal sites for the restriction endonuclease 
EcoRI were methylated by using EcoRI methylase and S-adenosyl 
methionine. EcoR! linkers (GGAA TTCC) were ligated to the ends 
of the cDNA with T4 DNA ligase. After digestion with EcoR!, 
cDNA were fractionated by Sepharose CL-4B column to remove 
the linker molecules, and ligated into the EcoRI site of Agt11 DNA, 
which is known to be located within the lac Z gene. The average size 
of the cDNA was about 1.5-kb nucleotide long. Packaging of the 
ligated DNA was done with Gigapack Gold (Stratagene, San Diego, 
CA). 
lntmunoscreening Screening of clones expressing the fusion 
protein of the BP antigen was done as previously described [22) with 
a few modifications. E. coli YI090 cells were grown at 37°C in 
10 ml of LB medium (10 gil bacto-trypton (Difco, Detroit, MI), 
5 gil bacto-yeast extract (Difco), 10 g/I NaCI, pH 7.5) supple-
mented with 10 mM MgS04 , 0.4% maltose, and 50 ,ug/ ml ampi-
cill in until the OD660 reached 0.3 . The cells were harvested by 
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centrifugation, resuspended in 5 ml ofl0 mM MgS04 • Phage solu-
tion containing approximately 104 phages in TMG buffer (0.1 M 
NaCl, 50 mM Tris-HCl, pH 7.5,10 mM MgS04 , and 0.01 % gela-
tin) was incubated with 100 - 200,u1 of Y1090 cell suspension at 
37"C for 20 min. This mixture was plated with 3 ml of LB top 
agarose containing 10 mM MgS04 , 0.4% maltose, and 50,ug/ml 
ampicillin on 90-mm LB-agar plates containing 50 ,ug/ml ampicil-
lin. After the plates were incubated at 42 °C for 3-4 h, nitrocellu-
lose filters (Schleicher and Schnell), presoaked in30 mM isopropyl-
fJ-thiogalactopyranoside(IPTG), were overlaid on the plaques and 
incubated overnight at 37°C. 
The filters were washed twice with TTBS (10 mM Tris-HCl, pH 
8.0; 150 mM NaCl; and 0.05% Tween 20) to remove any remnants 
of agar, and then blocked with 20% calf serum (CS) (Boehringer 
Mannheim) in TTBS for 1 h. The filters were then incubated with 
MoAb-5E in TTBS containing 10% CS for 1 h. After washing 3 
times with TTBS, the filters were incubated for 30 min with 
1 : 1000 di luted alkaline-phosphatase coqjugated anti-human 
Ig(G + A + M) goat antiserum (Zymed, San Fra'ncisco, CA). Fi-
nally the filters were washed 3 times in TTBS, damp dried, and 
incubated with a fresh ly prepared color development solution [0.33 
mg/ml nitro blue tetrazolium (Sigma) and 0.17 mg/mI5-bromo-4-
chloro-3-indolyl phosphate (Sigma) in 100 mM Tris-HCl, pH 9.5, 
containing 100 mM NaCI and 5 mM MgCI2] for 10-30 min, fol-
lowed by rinsing with water. The whole process was performed at 
room temperature. 
The reactivity of the fusion protein produced by the positive 
clone was tested by immunostaining as mentioned above, by using 
sera from patients with bullous pemphigoid and pemphigus, and 
from normal individuals as the sources of primary antibodies. 
Northern Blot Analysis The size of the mRNA hybridized to 
the cloned cDNA was determined by Northern blot analysis. Total 
RNA (20,ug, 5,ug) or poly(A)+ RNA (2,ug) from Pam cells was 
electrophoresed in formamide/agarose gels, then transferred to ny-
lon membrane (Gene Screen Plus, New England Nuclear, Boston, 
MA) [23]. The membranes were preincubated at 42 °C for 6 h in 
hybridization solution (50% formamide, 1 % SDS, 1 M NaCl , 10% 
dextran sulfate). [32P]-labeled DNA probes were prepared by the 
oligolabeling system (P harmacia) with the cloned cDNA as a tem-
plate. Denatured herring sperm DNA (100 ,ug/ml) and denatured 
DNA probe (106 cpm/ml) were added to the hybridization solution 
and incubated at 42°C overnight. The membranes were washed 
twice in 2X SSC (20X SSC: 3 M NaCI, 0.3 M sodium citrate, pH 
7.0) at room temperature, twice in 2 X SSC containing 0.1 % SDS at 
65 ° C, and then twice in 0.1 X SSC at room temperature. The mem-
branes were subjected to autoradiography. 
Restriction Mapping and DNA Sequence Analysis Phage 
DNA was prepared as described previously [24] , and digested with 
EcoR!. The insert DNA was purified by agarose electrophoresis and 
subcloned into the EcoR! site of plasmid pUC9 DNA. The plasmid 
DNA was prepared as previously described [25J and digested with 
various restriction enzymes, followed by agarose gel electropho-
resIs. 
The plasmid DNA harboring the cloned cD NA was digested by 
restriction enzymes. The desired DNA fragments were isolated 
from the agarose gel and subcloned into bacteriophage M13 mp18 
or mp19. DNA sequencing was performed by the dideoxynucleo-
tide chain-termination method described by Sanger et al [26] . 
RESULTS 
Immunoblot Analysis To characterize the BP antigen in Pam 
cells, we analyzed SDS extracts of Pam cells by immunoblotting 
with sera from BP patients and MoAb-5E (Fig 1). The BP sera (lal1es 
1 arId 2) recognized a 230-kD protein that is known as the major BP 
antigen [7 -12]. However, non-specific bands were also seen, proba-
bly because patients ' sera also contained antibodies reacting with 
keratins or some other proteins produced by Pam cells. On the other 
hand, MoAb-5E (Ialle 3) specifically recognized the 230-kD pro-
tein. Because Pam cells produce the 230-kD BP antigen and MoAb-
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Figure 1. Immunoblot analysis of the BP antigen from Pam cells. SDS 
extracts of Pam cells were electrophoresed, transferred to nitrocellulose 
filters, and stained with sera from BP patients (lanes 1 and 2), MoAb-5E (lane 
3) , and a normal human serum (la/le 4). Lalle 5 is molecular weight stan-
dards. A rrow, th e 230-kD DP antigen that is recognized by DP sera and 
MoAb-5E. 
5E specifically reacts with it, we planned to obtain a cDNA clone for 
the 230-kD BP antigen by screening a Pam cell cDNA expression 
library with MoAb-5E as an antibody probe. 
Immunoscreening of a cDNA Agt11 Library The cDNA ex-
pression library was constructed from poly(A)+ RNA of Pam cells 
by using Agtll as an expression vector. Recombinant phages were 
plated with E. coli Y1090 and plaques were immunoscreened with 
MoAb-5E. Upon the first screening of 1.5 X 105 clones, five candi-
date clones were obtained. After repeated isolation and screening of 
these clones, we finally obtained one positive clone, which was 
designated BPM1. Figure 2A shows the second screening of the 
fusion protein produced by BPM 1, which was stained in a doughnut 
like pattern with a c1.ear cente:. Figure 2B depicts the reactivity of 
MoAb-5E to this fusIOn prote1l1 111 companson to that of a normal 
human serum. The fusion protein was stained with MoAb-5E but 
not with the normal human serum. This result indicated that the 
fu sion protein has an epitope that is specifically recognized by 
MoAb-5E. 
To confirm that the fusion protein only reacts with sera from BP 
patients, we analyzed the fusion ~rotein for its reactivity wit~ sera 
from patients with TIP and pemphigus, and from normalmdlVlduals 
(Fig 3). All of the sera from the ten BP patients showed a clear 
positive staining, whereas sera from seven pemphigus patients ~nd 
five normal individuals showed only a low background of reactivity . 
Figure 3 shows representative results . 
Northern Blot Analysis of the BP Antigen mRNA To char-
ac terize the BPM1 cDNA, we isolated total and poly(A)+ RNA 
fro m Pam cells and examined the size of the BPM1 mRNA by 
Northern blot analysis. Figure 4 shows that the BPMl mRNA is 
approximately 9 kb long, which is compatible with the size of the 
mRNA deduced from the molecular weight of the 230-kD protein. 
Restriction Mapping and DNA Sequence Analysis Figure 5 
shows a restriction endonuclease cleavage map and sequence strat-
egy for the BPMl cDNA clone. The sequen ce of the cDNA was 
confirmed by sequencing from both directions . The nucleotide and 
deduced amino acid sequences are shown in Fig 6. BPM1 cDNA 
was 3234 nucleotides long and had a 2991-bp open reading frame 
(ORF) continued from upstream of the 5' end of this eDNA and a 
putative poly(A)signal (AATAAA) at 3' end. This reading frame 
cou ld encode a polypeptide of 997 amino acids with a molecular 
mass of approximately 115 kD, which is about half of the intact 
230-kD BP anti gen. The other two frames and the three frames in 
the opposite direction showed multiple stop codons. 
Next we compared the nucleotide and deduced amino acid se-
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Figure 2. Screening. by immunostaining of the cDNA expression library 
with. MoAb-5E. A : Immunostaining of plaques of the partially purified 
positive clone (RPM1). Arrowheads, positive clones that were stained in a 
doughnut-like pattern with a clear center. B: immunostaining of plaques of 
the purified BPMl with MoAb-5E (5E) and a normal serUm (NS). 
quences with those of the human cDNA clone for the 230-kD BP 
antigen reported by Stanley et al [27]. The BPMl cDNA, a mouse 
c1<:ll1e, shared 78.6% DNA sequence homology and 77.0% amino 
aCid sequence homology with the human clone in the coding re-
gion. The localization of these two clones is shown in Fig 5 and rhe 
comparison of the nucleotide and amino acid sequences is shown in 
Fig 6. The hydrophilicity profiles of mouse and human 230-kD BP 
antigen was calculated and compared in Fig 7 . 
DISCUSSION 
To characterize the 230-kD BP antigen, we constructed a cDNA 
library from a mouse epidermal cell line, Pam cells, and obtained a 
cDNA clone expressing the DP antigen. We surveyed several cul-
tured keratinocytes, namely, Pam cells [18], SV40-transformed hu-
man keratinocytes (It], and a primary culture of normal human 
keratinocytes for the expression of BP antigen by immunoblottin" 
or immunoprecipitation with BP patients' sera. Pam cells expressed 
the 230-kD BP antigen at the highest level in our experimentru 
conditions (data not shown). Therefore, we used Pam cells as a 
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Figure 3. Immunos~aining of the fusion ~rote in produced by. BPM 1 with 
sera from patients with bullous pemphigOId (BP) and pemplllg~s (P) , and 
normal individuals (N). All BP sera react with the fusIOn protem, but the 
pemphigus and normal control sera do not. 
source for a cDNA expression library. We used random hexamers, 
P(N)6, to synthesize cD N A instead of the o lig~( dT) primer P~ dT)n· 
Equal representation of all mRNA sequences 111 the cDNA hbr~ry 
was considered to be essential, because the size of the putative 
mRNA of the 230-kD protein was deduced to be 9 to 10 kb long and 
the localization of the epitopes in the 230-kD protein was un-
known. 
1 2 3 
...... 285 
~ 185 
Figure 4. Northern blot analysis of the mRNA of BPM1. Total RNA and 
poly{A)+ RNA from Pam cells was electrophoresed and transferred to a 
nylon membrane, followed by hybridization with radiolabeled BPMl as a 
DNA probe. Lalle 1, 21lg of poly{A)+ RNA. Lalle 2, 20llg of total RNA. 
Lane 3, Sllg of total RNA. A rrowheads, the origin of electrophoresis and the 
positions of the 28S and 18S rRNA. BPM 1 cDNA hybridizes to an approxi-
mately 9-kb mRNA. 
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Figure 5. Restriction map and sequencing strategy for the BPMl cDNA. 
Open box, coding region. Solid bar, non-coding region. Horizolltallilles and 
arrows in the center indicate fragments and their directions sequenced. BP, 
human clone for the 230-kD BP antigen reported by Sta)lely et al [27]. The 
BPMl cDNA shares 78.6% DNA sequence homology with the human 
clone. 
In this study, we obtained one positive clone (BPM 1) that reacted 
with a human monoclonal antibody against basement membrane 
zone (MoAb-5E) but not with a normal human serum. We con-
cluded that this BPM1 cDNA clone contains the coding sequence 
for the 230-kD BP antigen for the following reasons. First, the 
fusion protein produced by BPMl was reactive with MoAb-5E, 
which exclusively recognized the 230-kD BP antigen. Second, all 
of the ten BP sera, but none of the seven pemphigus or the five 
normal sera tested reacted with the fusion protein produced by 
BPMl. Third, the size of mRNA for BPM1 was large enough to 
encode the 230-kD BP antigen and was the same size (9 kb) as 
reported for the mRNA encoding the human BP antigen [27]. 
A number of antigens have been cloned by screening cDNA 
expression libraries with patients ' polyclonal autoantibodies [27-
33J. However, one of the difficulties is to determine whether a 
positive clone obtained by immunoscreening really has the coding 
sequence for the tar~et molecule. To confirm this,. several tech-
ni~ues are known: epltope selectlo:1 [27 ,29 - 31]' peptide map analy-
sis [28,32,33], hybrid-arrested or released in vitro translation [28] , in 
vitro transcription and translation [33], or immunization of various 
animals with the fusion protein [30]. Patients' polyclonal sera often 
contain antibodies that react with many other molecules. U se of a 
specific and well-characterized MoAb makes such characterization 
unnecessary. In this study an anti-BMZ human MoAb that specifi-
cally reacts with the 230-kD BP antigen was used [17J. This MoAb 
also facilitated selection of positive clones because of the very low 
background level. 
The BPMl cDNA is 3234 bp and has a coding sequence of2991 
bp for the c~rbox~1 terminus of the BP antigen. However, the ~irec­
tion of the 111sertlOn of BPM1 cDNA was found to be opposite to 
that of the lac Z gene (data not shown) . Though the mechanism for 
the expression of the BPM1 gene is not understood, similar phenom-
ena in the Agtl1 system have been reported suggesting that the 
transcription depends on the late lambda promoter [27,34,35J. 
The comparison of amino acid sequences between mouse and 
human 230-kD BP antigens indicated that 511 of 664 correspond-
ing amino acids (77.0%) were identical and 57 of 153 substituted 
amino acids (37.3%) represented conservative changes [36]. These 
findings indicate that the amino acid sequence of the carboxy one 
third of the BP antigen of mouse and human are highly homolo-
gous, suggesting that the antigen has been evolutionall y conserved 
and, therefore, probably serves an important physiologic function in 
the basement membrane of stratified squamous epithelia. These 
findings are also consistent with immunofluorescence data that 
shows the conservation of at least some epitopes in the BP antigen in 
various vertebrates [37] . 
Antibodies raised against proteins generally recognize two types 
of epitopes. One is a noncontinuous and conformational epitope of 
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CTA GCC CAA AGT CAA AAC CTA GTA AGC GAG TTC AAG CAA AAG TGT GAC CAG CAG AGC ATG ATC ATC CAG AAA ACG GAG AAG GAG GTG AGG 9Q 
Leu Ala Gln Ser Gln Asn Leu Val Ser Glu Phe Lys Gln Lys Cys Asp Gln Gln Ser Met Ile Ile Gln Lys Thr Glu Lys Glu Val Arg 30 
AGC CTG AGC GCA GAA CTG AGC GCG TCC AAA GAG GAG AAG CGG CGG GAA GAG CAG AAG GCT CAG CTG CAG CGA GCT CAG GTG CAG GAG CTG 180 
Ser Leu Ser Ala Glu Leu Ser Ala Ser Lys Glu Glu Lys Arg Arg Glu Glu GIn Lys Ala GIn Leu GIn Arg Ala GIn Val Gln Glu Leu 60 
A TAT A A GAG T T T 
AAT GAC AGG CTG AAG AGG GTG CAA GAC GAG CTG CAC CTG AAG ACC ATC GAA GAG CAG ATG ACC CAC AGG AAG ATG ATC CTG CTC CAG GAA 270 
Asn Asp Arg Leu Lys Arg Val Gln Asp Glu Leu His Leu Lys Thr lIe Glu Glu GIn Het Thr His Arg Lys Het lIe leu Leu GIn Glu 90 
GLU Val Phe 
A T G A AA A G A A T A A AT A T 
GAG TCG GAT AAG TTC AAA eGe TCG GCA GAT GAG TTT eGG AAG AAG ATG GAG AAG eTA ATG GAG TCC AAG GTC GTC ACT GAA ACC GAT CTe 360 
Glu Ser Asp Lys Phe Lys Arg Ser Ala Asp Glu Phe Arg Lys Lys Met Glu Lys Leu Met Glu Ser Lys Val Val Thr Glu Thr Asp Leu 120 
Gly GIn Glu Ile Asn lIe 
T G TT 
TeA GGe ATC AAG CAC GAC TTT GTG TeT 
Ser Gly Ile Lys His Asp Phe Val Ser 
Arg Leu 
T A CA CT A A CAT T T T A A AA A 
CTe CAG AGA GAA AAC TTC CGG GCG CAA GAG AAe GeG AAG CTG TGG GAG ACe AAe ATT CGA GAG 
Leu GIn Arg Glu Asn Phe Arg Ala GIn Glu Asn Ala Lys Leu Trp Glu Thr Asn lIe Arg Glu 
GIn Ser Cys Lys 
A A A A CAG T A C A G A A A T T C A A T A A T 
450 
150 
CTT GAG CGG CAG CTT CAG TGC TAC CGT GAG AAG ATG CAG CAA GGC CCG cce GTG GAA GCA AAC CAC TAT CAG AAG TGe CGG AGA eTC GAG 540 
Leu Glu Arg GIn Leu GIn eys Tyr Arg Glu lys Met GIn GIn Gly Pro Pro Val Glu Ala Asn His Tyr GIn lys Cys Arg Arg leu Glu 180 
Gln GIn GIn His Met GIn lys " 
T A A AG T G G G A C A G A T A A G TT 
GAG GAG CTG TTG GCC CAG AGA CGG GAA GTT GAA AAe CTe AAA CAA AAA ATG GAe CAG eAG ATA AAG GAA CAT GAG CAe eAG TTG err eGG 630 
Glu Glu Leu Leu Ala Gln Arg Arg Glu Val Glu Asn Leu Lys Gln Lys Met Asp Gln Gln Ile Lys Glu His Glu His Gln Leu Leu Arg 21 0 
Asp Ile Lys Val leu 
TAG A TGT AAA C A A G TAT AG G T 
CTC CAG TGT GAA ATC CAA AAG AAG AGC ACA ACC CAA GAe CAC Ace TTC GCG TCG GCT TTT GAT AeG GeA GGG AGA GAG TGe eAC CAe eeT 720 
Leu GIn eys Glu lIe GIn Lys Lys Ser Thr Thr GIn Asp His Thr Phe Ala Ser Ala Phe Asp Thr Ala Gly Arg Glu Cys His His Pro 240 
Ala lys Cys Lys Pro Asp Glu Met Thr Val Lys GIn Ser 
G e G T A A A A C C CA C " TC T TG A ~ A G CA TTG 
GeA GAG ATC Tee eeT GGG AAe TCT GGG eAe eTT AAe eTA AAG Ace AGA CTe eCA eTG Tec AGG TGG ACT CAG GAG CCA CAe CAG AeA GAA 81 0 
Al a "Glu lIe Ser Pro Gly Asn Ser Gly His Leu Asn Leu Lys Thr Arg Leu Pro Leu Ser Arg Trp Thr GIn Glu Pro His Gln Thr Glu 270 
Gly Leu Ser Arg Thr His Pro Thr Pro Ser Leu Gln Pro Leu 
AG GAT C T T G A A C A A C A AG CA A C G AA AA 
GGA AAA TGG CeG CAC AGG GCT GCT GAA CAA CTT eeG AAG GAG GTT eAG TTe eGA eAG eeA GGG GeT eeG eTG GAe AGG GAG AGe AGe eAG 900 
Gly lys Trp Pro His Arg Ala Ala Glu GIn Leu Pro Lys Glu Val GIn Phe Arg GIn Pro Gly Ala Pro Leu ASp Arg Glu Ser Ser GIn 300 
Glu Gln Val Val Ile Gln Pro Glu Lys Lys 
AG T T e C G TAG e C T A A A T 
eCA TGC TAC TeG GAG TAT TTT TeT eAG AeA AGe AeT GAA eTG eAG ATA ACT TTT GAT GAT AAA AAC eeA ATe AeG eGA eTG TeT GAA eTA 990 
Pro eys Tyr Ser Glu Tyr phe Ser Gln Thr Ser Thr Glu Leu Gln Ile Thr Phe Asp Asp Lys Asn Pro Ile Thr Arg Leu Ser Glu Leu 330 
GIn Glu Thr lIe 
A A A 
GAG AeG ATG AGG 
Glu Thr Met Arg 
Lys lIe 
e A C AAT TAT T G A A Ge TG T A e G 
GAG eAA Gee eTG CAT eee Tee AGA eeG eeG GTG AeG TAT eAG GAT GAe AAA eTT GAA AGG GAG TTG GTG AAG eTT TTG 
Glu GIn Ala Leu His Pro Ser Arg Pro Pro Val Thr Tyr Gln Asp Asp lys Leu Glu Arg Glu Leu Val lys Leu Leu 
Asp Asn Asn Arg Asn Ala eys Met Val 
G A AT A A A Ae eA T C 
1080 
360 
ACA ece TTA GAG ATA GeT AAG AAe AAA eAG TGT GGe ATG CAT AeA GAA GTC AeG Aec TTA AAA eAA GAG AAG AGG eTG GGT Tee AGT GeT 11 70 
Thr Pro Leu Glu lIe ALB Lys Asn Lys GIn eys Gly Met His Thr Glu Val Thr Thr leu Lys GIn Glu Lys Arg Leu Gly Ser Ser Ala 390 
Thr Asp Asn Pro Val Pro 
'~G AA A T G lr GG T A Ae T A A 
GGr GGA TGG ATG CTG GAA GGG TGC AGA AeA TCT GGT GGA eTe AAG GGA GAT TTe eTT AAG AAA AGe GTA GAG eeA GAG GCT Tee eeG AGe 
Gly Gly Trp Met Leu Glu Gly eys Arg Thr Ser Gly Gly Leu Lys Gly Asp Phe Leu Lys Lys Ser Val Glu Pro Glu Ala Ser Pro Ser 
Glu Glu Ala Gly Leu Thr phe GIn Asn 
T T GG G T TAT A eTA A ACT T 
crr GAC err AAe eAG GeG TGe TeT GTT AGG GAT GAG GAG TTT CAG TTT CAA GGG eTC AGG CAe Ace GTG ACT 
leu Asp Leu Asn Gln Ala eys Ser Val Arg Asp Glu Glu phe GIn Phe Gln Gly Leu Arg His Thr Val Thr 
Ph e Gly Asp His Asp lys 
C T G 
GGe AGG CAG eTG GTe GAA 
Gly Arg GIn leu Val Glu 
Ala 
T T A A Ae T T Ae A 
1260 
420 
1350 
450 
GCe AAG eTC CTG GAC ATG AGG ACA GTT GAG CAG CTG CGG CTT GGT CTG AAG ACT GTC GAA GAA GTT CAG AGA AGT CTT AGC AAG TTT CTG 1440 
Ala lys leu Leu Asp Met Arg Thr Val Glu GIn leu Arg Leu Gly leu Lys Thr Val Glu Glu Val GIn Arg Ser Leu Ser Lys Phe Leu 480 I 
Ile Lys Thr Asn 
A 
Figure 6. Nucleotide and amino acid seq~ences of the BPMl eDNA compared :-vith the human eDNA" First line, nucleotide sequence of the human cD~A 
which differs from BPMl eDNA. Seco /ld litle, nucleotide segucnce ofBPMl. Thad l'lle, deduced ammo aCid scguence encoded by BPMl cDNA. Fo urt/l/lllt, 
amino acid sequence for the human 230-kD BP antigen that differs from the mouse. 
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G C A G C A A G TAT G C A G G 
ACC AAA GCT ACC TCC ATT GCA GGA CTT TAT CTA GAA TCT TCC AAA GAA AAA ATG TCG TTC ACT TCG GCG GCC CAG AAA ATC ATA ATA GAC 1530 
Thr Lys Ala Thr Ser lIe Ala Gly Leu Tyr Leu Glu Ser Ser Lys Glu Lys Met Ser Phe Thr Ser Ala Ala GIn Lys lIe lIe lIe Asp 510 
Thr lIe Ala Glu Arg 
G G T G A C A A A T C 
AAA ATG ATA GCT CTA GCC TTT TTA GAA GCT CAG GCT GCA ACA GGT TTT ATA ATT GAT CCG GTT TCT GGT CAG ACT TAC TGT GTT GAA GAT 1620 
Lys Met lIe Ala Leu Ala Phe Leu Glu Ala Gln Ala Ala Thr Gly Phe Ile Ile ASP Pro Val Ser Gly Gln Thr Tyr Cys Val Glu Asp 540 
Val Ile Ser 
A A A G T C C A A TT T T C G T T T 
GCA GTT CTT CAT GGC ATC GTT GAT CCT GAG TTC AGG AGC AGG CTC CTG GAG GCA GAG AAG GCA GTT TTG GGA TAT TCA CAT GCT TCT AAG 1710 
Ala Val Leu His Gly Ile Val Asp Pro Glu Phe Arg Ser Arg Leu Leu Glu Ala Glu Lys Ala Val Leu Gly Tyr Ser His Ala Ser Lys 570 
Lys Val Ile Ala Val Tyr Ser 
A T TAT C A C A A C G T 
ACG CTG TCA GTG TTC CAG GCA ATG GAA AAT AGA ATG CTT GAT AGG AAG AAA GGT AAA CAT ATC TTG GAG GCA CAA ATT GCC AGT GGG GGC 1800 
Thr Leu Ser Val Phe Gln Ala Met Glu Asn Arg Met Leu Asp Arg Lys Lys Gly Lys His lIe Leu Glu Ala Gln Ile Ala Ser Gly Gly 600 
Gln 
A T T T C G T T TAT T T A 
GTC ATT GAC CCT GTG AGA GGC GTC CGT GTC CCT CCA GAA ATG GCT GTG CAG CAG GGC TTG CTG AAC AAC GCC GTC CTA CAG TTC CTG CAT 1890 
Val Ile Asp Pro Val Arg Gly Val Arg Val Pro Pro Glu Met Ala Val Gln Gln Gly Leu Leu Asn Asn Ala Val Leu Gln Phe Leu His 630 
Ile Ile Leu Ile 
G A A T C T A C A A GA G A 
GAA CCG TCC AGC AAC ACG AGA GTC TTT CCT AAT CCC AAC AAC AAG CAG GCT CTG TAT TAT TCG GAG TTA CTG CAG ATC TGT GTG TTT GAT 1980 
Glu Pro Ser Ser Asn Thr Arg Val Phe Pro Asn Pro Asn Asn Lys Gln Ala Leu Tyr Tyr Ser Glu Leu Leu Gln Ile Cys Val Phe Asp 660 
Arg Met 
G C A C G T A ACT 
GTA GAT TGC CAG TGT TTT CTC TTG CCG TTT GGG GAG AGG GAA ATA TCC AAT 
Val Asp cys Gln Cys Phe Leu Leu Pro Phe Gly Glu Arg Glu Ile Ser Asn 
Glu Ser Phe Asn 
T G C A A 
CTC AAC ATA GAG AAA ACT 
Leu Asn Ile Glu Lys Thr 
Val Lys 
G T T A 
CAT AAA ATT GCC GTG 
His Lys Ile Ala Val 
Arg Ser 
GTA GAT 
Val Asp 
T A A TAT C TG AT G A A A T T CT 
GGG CAG CAG 
Gly Gln Gln 
-- - Pro 
ACC AAA ACT GGG GCG GAA CTG ACG GCA TTC GAG GCT TTC CAG AGA AAC CTG ATT GAC AAG GGT ATT TAT CTC GAA CTC TCA 
Thr Lys Thr Gly Ala Glu Leu Thr Ala Phe Glu Ala phe Gln Arg Asn Leu lIe Asp Lys Gly lIe Tyr Leu Glu Leu Ser 
Ser Val Tyr Glu Ser 
T TG GAT CA G TT T T A C AGG A A A AAA TGA 
2070 
690 
2160 
720 
TAT CAG TGG AAG GAA GCT ACA TTT TTT GAC TCC TAC GGG CAT CCT TCT CAC ATG CTG ACT GAT ACT AAA ACT GGT CTG CAG TTC AAT ATT 2250 
Tyr Gln Trp Lys Glu Ala Thr Phe Phe Asp Ser Tyr Gly His Pro Ser His Met Leu Thr Asp Thr Lys Thr Gly Leu Gln Phe Asn lIe 750 
Phe Trp Asp Thr Gly Phe Ser Leu Arg Lys Lys END 
AGT GAA GCT GTC GAG CAG GGA ACG CTA GAC AAA GCC TTG GTG CAA AAG TAT CAG GAA GGC CTA ACT ACA CTA ACA GAA CTG GCT GAC TTT 
Ser Glu Ala Val Glu Gln Gly Thr Leu Asp Lys Ala Leu Val GIn Lys Tyr GIn Glu Gly Leu Thr Thr Leu Thr Glu Leu Ala Asp phe 
CTT CTG AGC AAG GTA GTT CCC AAG AAG GAT TTG CAC AGT CCC ATT GCA GGC TAT TGG CTG ACC GCT AGT GGG GAG CGA ATC TCC TTG CTG 
Leu Leu Ser Lys Val Val Pro Lys Lys Asp Leu His Ser Pro lIe Ala Gly Tyr Trp Leu Thr Ala Ser Gly Glu Arg Ile Ser Leu Leu 
AAA GCC TCC CGT AGA AAC TTG GTT GAT AGG GTT ACA GCC CTC AGA TGC CTT GAA GCC CAA ATC TGT ACA GGA GGG ATC ATC GAT CCC CTA 
Lys Ala Ser Arg Arg Asn Leu Val Asp Arg Val Thr Ala Leu Arg Cys Leu Glu Ala Gln Ile Cys Thr Gly Gly Ile Ile Asp Pro Leu 
ACT GGG AAA AAG TAC AGG GTG GCC GAG GCT TTG CAT AGA GGG CTG GTG GAC GAG GGC TTC GCC CAG CAG CTA CGC CAG TGT GAA TTA GTG 
Thr Gly Lys Lys Tyr Arg Val Ala Glu Ala Leu His Arg Gly Leu Val Asp Glu Gly Phe Ala GIn GIn Leu Arg GIn Cys Glu Leu Val 
ATC ACG GGG ATC AGC CAC CCC GTC AGC AAT AAA ATG ATG TCA GTG GTG GAA GCC GTG AAT GCA AAT ATC ATC AGT AAA GAA ATG GGC ATG 
Ile Thr Gly lIe Ser His Pro Val Ser Asn Lys Met Met Ser Val Val Glu Ala Val Asn Ala Asn lIe lIe Ser Lys Glu Met Gly Met 
CGG TGC CTG GAA TTT CAG TAC CTG ACA GGG GGC CTG ATA GAG CCG AAG GTT TTC TCG AGG CTG ACC ATA GAA GAG GCC CTT CAC GTC GGT 
Arg Cys Leu Glu Phe GIn Tyr Leu Thr Gly Gly Leu lIe Glu Pro Lys Val Phe Ser Arg Leu Thr Ile Glu Glu Ala Leu His Val Gly 
ATC ATT GAT GTC CTC ATC GCC ACC AGA CTC AAA GAT CAA AAG TCA TAT GTC AGG GAT ATA ATG TGC CCC CAG ACT AAG AGA AAA TTG ACA 
Ile lIe Asp Val Leu lIe Ala Thr Arg Leu Lys Asp Gln Lys Ser Tyr Val Arg Asp lIe Met Cys Pro GIn Thr Lys Arg Lys Leu Thr 
TAT AAA GAG GCC CTG GAG AAA GCT GAT TTT GAT TTC CAC ACA GGA CTT AAG CTG TTA GAA GTG TCT GAA CCC TTG GGG ACA GGG ATA TCC 
Tyr Lys Glu Ala Leu Glu Lys Ala Asp Phe Asp Phe His Thr Gly Leu Lys Leu Leu Glu Val Ser Glu Pro Leu Gly Thr Gly Ile Ser 
AAC CTC TAC TAT TCT TCC .CAG TAG GGC GTT TGA CTC TGT GCA GAG GCC GTG TCG GCT GCA TCC TGC CAT CTG TTC AGA GCA GAT GGT GTC 
Asn Leu Tyr Tyr Ser Ser Gln END 
TGC TAA ATG TGC AGC CTA GGA ACT GTG TCA CCA ACT CGA AGC GCT GTT AAT TTC TTG TAG GCT AGA AAT AGC TCC CTG CTC AGA AAA CAC 
GGC CAT TCT TAA GTT GAA AGC AGA AAA CGA TTG GCT GCC eCT GAC AAA GTA ACT TAA AAA AAA AAA TAT CTT ACT AAA ATA AAT 
B 
2340 
780 
2430 
810 
2520 
840 
2610 
870 
2700 
900 
2790 
930 
2880 
960 
2970 
990 
3060 
997 
3150 
3234 
Figure 6. (Colllilwed) Ullderlill ed seqllell ce, putative poly(A)signal. The nucleotides and amino aeids were numbered from the 5' end and the amino terminal end 
of the BPMl eDNA, respectively, shown in the rig/It CO /II III II . The human clone corresponds to the mouse clone from nucleotide pos ition 208-2202. The 
human clone has additional AAA(Lys) at nucleotide position 1215. 
258 AMAGAI ET AL 
30 
20 
10 
0 
- 10 
- 20 
- 30 ..... .~ . . , .. .. - _., 
. --'-' - . --
50 100 150 200 250 300 
30 
.;:- 20 
] 10 
:c 0 a. 
~ 
-0 
>-
I 
- 30 · 
350 400 450 500 550 600 
30 
20 
10 
0 
650 700 750 800 850 900 
Number of Amino Acids 
Figure 7. Compari son of hydro phi Ii city pro fil es of mouse and human 230-
kD BP antigens. H ydrophilic and hydrophobic scores were calculated ac-
cordin g to the algorithm of Hopp and W oods [39J with an averaging win-
dow of 6 amino acids alld plotted with hydrophilic residues as positive 
(Beckman, Microgcni e program, Palo Alto, CA). Solid /iH e, mouse; dotted 
line, human; closed circle, on the bottom of rhe graph, an amino acid subs titu-
tion between mouse and human. The human done corresponds to the mouse 
cl one ft:om position 70 to 734. Some regions are well conserved and hydro-
philic. 
tertiary structure. The o ther is a continuous and sequence-depen-
dent epitope of a certain length of peptide [381. The 230-kD BP 
antigen is considered to have at leas t some sequence-dependent 
epito pes because it is recog nized by patienrs' antibodies under the 
reduced and den aturing conditions of immunoblotting . These epi-
topes may be hi ghl y co nserved or identical between mouse and 
human, because the recombinant protein produced by mouse BPM1 
cDNA was recogn ized by human MoAb and patients' se ra. In partic-
ular, the nine regions from amino acid positi ons 70- 85,101-114, 
187-208, 302-319, 478-493, 514 -530 , 569- 585, 587- 607 , 
and 626 - 654 were identica l between th e two species along more 
t\1dn 14 amino acids. In addition, epito pes, or antigenic determi-
nants, have a tendency to loca lize on the surface of the molecule in 
o rder to bind th e appropriate antibodies, and can be predicted fro m 
amino acid sequences by calculating a pro tein 'S hydrophiliciry pro-
fil e [391. Therefore , highly conserved and also hydrophilic regions, 
such as positions 187 - 208 o r 587 - 607, ar e good candidates for 
anti genic determinants o f th e 230-kD BP antige n (Fig 7) . For verifi-
cation , epitope mapping for M oAb-5E and BP patients' sera should 
be carried out w ith a series of deletion mutants ofBPM 1 cDNA and 
synthetic peptides. 
There were two regions that w ere not well conserved between 
mouse and human. In 58 amino acids of BPM.1 at position 221 -
278, 31 amino acids (53.4%) were different from the human pro-
te in. T wenty-nve of these 31 substituted amino acids showed non-
conservative changes. Position 71 9 - 733, w hich corresponded to 
the carboxyl terminal 15 amino acids of the human co unterpart, had 
13 amino acid repl acements (86.7%), in w hich 11 substituted amino 
acids showed non-conservative chan ges. Furthermore, the m ouse 
clone encoded an additional 273 amino acids at the carboxy l termi-
nus. 
This BPMl cDNA clone should be extremely valuable not onl y 
for characteriza tion o f the 230-kD BP anti gen, including epitope 
mapping, but also for the diagnosis of BP, by enzyme-linked im-
T HE J OURNAL OF INVESTIGATIVE DERMATOLOGY 
m Ul1osorbent assay (ELISA) wi th recom binant proteins or syncheti 
peptides as antigens. Furthermore, this m o use cDNA clone shou.lQ 
p rove useful fo r pathophysio logic studies of the disease in which · 
vivo and in vitro m ouse m odels mi ght be used. The cod ing sequence 
should p ermit antibodies to be m ade against specific epitopes of BP 
antigen. These antibodies against BP antigen should p rove useful as 
tools, in those m.odel system s, for study of the pathophysiology 0' 
blister fo rmation in BP. Further studies o f these types are in progr 
in our laboratory. 
We wish to thmlk Dr. Kiyoshi Naga ta Jor tech nical adllice and lzelpJttI disCllssiolls. 
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